A Phase 3 Study of Nivolumab in Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (ATTRACTION-2): 2-Year Update Data
Gastric Cancer - Germany
doi 10.1007/s10120-019-01034-7
Full Text
Open PDFAbstract
Available in full text
Date
December 20, 2019
Authors
Publisher
Springer Science and Business Media LLC